Transcutaneous Electrical Stimulation for Spinal Cord Injury
(STEP-RAISE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine the safety and effectiveness of using electrical stimulation on the skin to help people regain movement after a spinal cord injury (SCI). Participants will receive either active or sham (placebo) electrical stimulation starting three days after their injury to assess improvements in movement ability. The trial seeks patients who have recently experienced a spinal cord injury affecting their neck or upper back and were admitted to the hospital within 12 hours of the injury.
As an unphased trial, this study offers patients the chance to contribute to groundbreaking research that could enhance recovery options for spinal cord injuries.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that transcutaneous electrical stimulation is safe for spinal cord injury patients?
Research has shown that transcutaneous electrical spinal cord stimulation (tSCS) is generally safe for people with spinal cord injuries. One study found that using tSCS alongside rehabilitation activities has a good safety record and does not cause major side effects, particularly concerning heart and blood pressure. Another study confirmed that tSCS is safe for use both in clinics and at home, and it can help improve strength in people with long-term spinal cord injuries.
These findings suggest that tSCS is well-tolerated and does not lead to serious side effects. The electrical stimulation, applied to the skin and carefully monitored, ensures safety during treatment. While individual experiences may differ, current evidence supports the safe use of this treatment.12345Why are researchers excited about this trial?
Unlike the standard treatments for spinal cord injury, which often involve medication and physical therapy, transcutaneous electrical stimulation (tSCS) offers a non-invasive approach by delivering electrical currents through the skin to stimulate nerve activity below the injury site. Researchers are excited about tSCS because it has the potential to enhance motor function and sensory recovery without the need for surgery or pharmaceuticals. This technique is particularly promising as it may offer quicker improvements in mobility and independence for patients with spinal cord injuries.
What evidence suggests that transcutaneous electrical stimulation is effective for spinal cord injury?
Research has shown that transcutaneous electrical stimulation (tSCS) may aid recovery from spinal cord injuries. In this trial, participants will receive either active tSCS or a sham treatment. Studies have found that tSCS can enhance balance, stability, and lower body movement, even in long-term cases. Patients who received tSCS alongside other treatments experienced better recovery after many sessions. Some benefits also included reduced pain following spinal cord injuries. Overall, early evidence suggests that tSCS might improve movement and recovery for those with spinal cord injuries.56789
Who Is on the Research Team?
Anastasia V Keller, PhD
Principal Investigator
University of California, San Francisco
Rajiv Saigal, MD, PhD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for individuals with recent spinal cord injuries. It's testing if starting electrical stimulation through the skin 3 days after injury is safe and helps in movement recovery. Participants will be in hospital/ICU, undergo tests, and receive either real or sham stimulation.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase 1 Treatment
Participants undergo several tests before and after a single 60-minute electrical stimulation treatment. Assessments include movement ability, blood and CSF draws, and spinal cord function using electrical stimulation.
Phase 2 Treatment
Comparison of active electrical stimulation to sham stimulation over 5 consecutive days. Daily assessments of movement ability, blood and CSF draws, and spinal cord function.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of neurological function and biomarker analysis.
What Are the Treatments Tested in This Trial?
Interventions
- Transcutaneous Electrical Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Congressionally Directed Medical Research Programs
Collaborator
United States Department of Defense
Collaborator